Aim and Objectives: To develop a simple, sensitive, cost-effective and reproducible UVspectrophotometric method and validate for the estimation of disodium edetate in topical gel formulations. Materials and Methods: Solution of disodium edetate reacts with ferric chloride to form complex in 0.1 N HCl giving λ max at 270 nm. Beer's law was obeyed in the concentration range of 5-50 µg/mL (r 2 = 0.9997). Results: The limit of detection and limit of quantitation were found to be 1.190 and 3.608 µg/mL, respectively. The results show that the procedure is accurate, precise, and reproducible (relative standard deviation < 1%), while being simple and less time consuming. Conclusions: The study concluded that the UV-spectrophotometric method could be used for the quantification of disodium edetate in pure form as well as in pharmaceutical formulations.
INTRODUCTION
Losartan potassium, a potassium salt of 2-Butyl-4-chloro-1-[[2-(1H-tetrazol-5-yl) [1,1-biphenyl]-4-yl]methyl]-1H-imidazole-5-methanol, represents the first of a new class of orally active non-peptide angiotensin II (Type AT 1 ) receptor antagonists employed in the management of essential hypertension. [1] Several methods have been developed using HPLC, LC-MS-MS, metabolite in biological fluids by HPLC and LC-MS-MS and capillary electrophoresis. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] The aim of the present work is to develop and validate a new, accurate, specific and reproducible HPTLC method for determination of losartan potassium as in solid-based tablet formulation and also in marketed oral solid dosage formulation (COZAAR Tablets). The proposed method was validated as per ICH guidelines [15] and its updated international convention. different 10 ml volumetric flask and diluted to volume with the methanol such that the final concentrations of losartan potassium were 5.0-30.0 mcg/ml. Both standards and samples (0.3 µl) were applied to the plates as 6 mm bands by means of a Camag Linomat IV sample applicator. After development of about 7 cm and drying of the plates, evaluation of both drugs was performed by scanning densitometry at λ=235 nm (drug λ max) by means of a camag TLC scanner III controlled by CATS.V.4.06 software (Camag). Peak areas were recorded for all the peaks. The amount of losartan potassium was computed from the peak area by use of the formula: Amount of losartan potassium = (Rspl x C x D x average weight)/ (Rstd x W), where Rspl is the area of the losartan potassium sample peak, Rstd is the area of the losartan potassium standard peak, C is the concentration of standard solution [mg/ ml], D is the dilution factor, and W is the weight of tablet (mg).
Calibration curves of losartan potassium
Calibration solutions of losartan potassium in methanol containing concentrations of losartan Potassium from 5.0 to 30.0 ng/ml were prepared by individual weighing. Five microliters from each solution was spotted on the HPTLC plate to obtain final concentration range of 5.0-30.0 ng per spot. Each concentration was spotted two times on the HPTLC plate. The data of peak area versus drug concentration were treated by linear least-square regression analysis.
Method validation
The HPTLC method developed was validated for following parameters.
Recovery studies
Recovery of losartan potassium was determined by spiking losartan potassium in drug to obtain three different concentrations covering the low, medium, and higher ranges of the calibration curve. The recovery was calculated by comparing the resultant peak areas with those obtained from pure standards in methanol at the same concentrations.
Precision and accuracy
Different amount of losartan potassium covering low, medium, and higher ranges of the calibration curve were spotted on the HPTLC plate. These spots were analyzed by using the above-described HPTLC method. Precision was expressed as the percent relative standard deviation (% C.V.) and accuracy was expressed as a percentage (observed concentration × 100/theoretical concentration).
Limit of detection and limit of quantification
These were calculated by use of the equations Limit of detection (LOD) =3 × N/B and limit of quantification (LOQ) = 10 × N/B where N is the standard deviation of the peak areas of the drugs (n=3), taken as a measure of the noise, and B is the slop of the corresponding calibration curve.
Analysis of marketed formulation
The developed method can be applied in determination of losartan potassium in COZAAR tablets, which is marketed oral solid dosage formulation.
To determine the contents of losartan potassium in tablets (COZAAR, label claim: 25 mg per tablet), the drug from the powder was extracted with 10 ml methanol. To ensure complete extraction of the drug, it was sonicated for 30 min. The resulting solution was allowed to settle for about an hour and the supernatant was suitably diluted to give desired concentration. The analysis was repeated in triplicate. The possibility of excipient interference in the analysis was studied.
RESULTS AND DISCUSSION
The mobile phase used was resolving the two drugs very efficiently, as shown in Figure 1 . HPTLC offers several advantages over reported methods. It facilitates automatic application and scanning in situ. The composition of the mobile phase for the development of the chromatographic method was optimized by testing different solvent mixtures of varying polarity. Acetonitrile-0.2% acetate (6:4, 7:3, v/v) and methanol-0.2% acetate (8:2, 9:1, v/v) were tried. The best results were obtained using acetonitrile- methanol-0.1% acetic acid (3.5:2.6:3.9, v/v). This mobile phase showed good resolution of losartan potassium peak from other formulation components or excipients tested. Densitometric scanning of all the tracks showed compound with Rf value 0.61 (single violet spot), identified as losartan potassium. The present method is quicker as the time needed for development of plate is reduced considerably to less than half an hour for chamber saturation. The method was successfully used in the analysis of losartan potassium from the tablet dosage forms, and in case of Cozaar Tablets without interference of the formulation excipients.
Recovery study
Results showed high extraction efficiency of losartan potassium from formulation components. The recovery of losartan potassium ranged from 96.58 to 98.27%, average of 97.33%. This confirms that the proposed method can be used for determination of losartan potassium in tablet formulation.
Precision and accuracy
Five microliter aliquots of samples containing 5.0, 15.0, and 30.0 ng losartan potassium were analyzed according to the proposed method. In order to control the scanner parameters, one spot was analyzed several times. By spotting and analyzing the same amount several times the precision of the automatic spotting device and the derivatization technique, was evaluated. The coefficient variation (% C.V.) for the analysis of eight replicates indicated good precision for the proposed TLC method (% C.V. consistently less than 5) and scanning eight spots in one run is the method of choice. Results obtaining were of good accuracy and high precision. The accuracy was found to be in the range of 88.76-98.88% and % C.V. in range of 1.02-6.81. The results are presented in Tables 1-3.
Limit of detection and limit of quantification
The limit of detection was 3.0 ng/ml and the limit of quantification was 16.0 ng/ml and the solutions were stable for the 3 days.
CONCLUSIONS
The developed HPTLC technique is precise, specific, accurate, and sensitive. It proves that the method is repeatable and selective for the analysis of losartan potassium as bulk drug and in pharmaceutical formulations without any interference from the excipients. 
